Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2013

01-12-2013 | Research Article

Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study

Authors: Janet Krska, Charles W. Morecroft, Helen Poole, Philip H. Rowe

Published in: International Journal of Clinical Pharmacy | Issue 6/2013

Login to get access

Abstract

Background Polypharmacy is increasing and managing large number of medicines may create a burden for patients. Many patients have negative views of medicines and their use can adversely affect quality of life. No studies have specifically explored the impact of general long-term medicines use on quality of life. Objective To determine the issues which patients taking long-term medicines consider affect their day-to-day lives, including quality of life. Setting Four primary care general practices in North West England Methods Face-to-face interviews with adults living at home, prescribed four or more regular medicines for at least 1 year. Interviewees were identified from primary care medical records and purposively selected to ensure different types of medicines use. Interviews were recorded, transcribed and analysed thematically. Results Twenty-one interviews were conducted and analysed. Patients used an average of 7.8 medicines, 51 % were preventive, 40 % for symptom relief and 9 % treatment. Eight themes emerged: relationships with health professionals, practicalities, information, efficacy, side effects, attitudes, impact and control. Ability to discuss medicines with health professionals varied and many views were coloured by negative experiences, mainly with doctors. All interviewees had developed routines for using multiple medicines, some requiring considerable effort. Few felt able to exert control over medicines routines specified by health professionals. Over half sought additional information about medicines whereas others avoided this, trusting in doctors to guide their medicines use. Patients recognised their inability to assess efficacy for many medicines, notably those used for prophylaxis. All were concerned about possible side effects and some had poor experiences of discussing concerns with doctors. Medicines led to restrictions on social activities and personal life to the extent that, for some, life can revolve around medicines. Conclusion There is a multiplicity and complexity of issues surrounding medicines use, which impact on day-to-day lives for patients with long-term conditions. While most patients adapt to long-term medicines use, others did so at some cost to their quality of life.
Literature
1.
go back to reference May M, Montori V, Mair F. We need minimally disruptive medicine. BMJ. 2009;339:485–7.CrossRef May M, Montori V, Mair F. We need minimally disruptive medicine. BMJ. 2009;339:485–7.CrossRef
2.
go back to reference Eton DT, se Oliveria DR, Egginton JS, Ridgeway JL, Odell L, May CR, Montori VM. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas. 2012;3:39–49.CrossRefPubMed Eton DT, se Oliveria DR, Egginton JS, Ridgeway JL, Odell L, May CR, Montori VM. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas. 2012;3:39–49.CrossRefPubMed
3.
go back to reference Campbell SE, Seymour DG, Primrose WR. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing. 2004;33:110–5.CrossRefPubMed Campbell SE, Seymour DG, Primrose WR. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing. 2004;33:110–5.CrossRefPubMed
4.
go back to reference Fox C, Richardson K, Maidment ID, Savva GM, Matthew FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C. Anticholinergic medication use in the older population: the MRC cognitive function and aging study. J Am Geriatr Soc. 2011;59:1477–83.CrossRefPubMed Fox C, Richardson K, Maidment ID, Savva GM, Matthew FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C. Anticholinergic medication use in the older population: the MRC cognitive function and aging study. J Am Geriatr Soc. 2011;59:1477–83.CrossRefPubMed
5.
go back to reference Alic A, Pranjic N, Ramic E. Polypharmacy and decreased cognitive abilities in elderly patients. Med Arch. 2011;65(2):102–5. Alic A, Pranjic N, Ramic E. Polypharmacy and decreased cognitive abilities in elderly patients. Med Arch. 2011;65(2):102–5.
7.
go back to reference Bowling A. Measuring health: a review of quality of life measurement scales. 2nd ed. Buckingham: Open University Press; 1997. Bowling A. Measuring health: a review of quality of life measurement scales. 2nd ed. Buckingham: Open University Press; 1997.
8.
go back to reference Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMed Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMed
9.
go back to reference Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. I don’t know how many of these [medicines] are necessary. A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2008;74:135–141. Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. I don’t know how many of these [medicines] are necessary. A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2008;74:135–141.
11.
go back to reference Nunes V, Neilson J, O’Flynn N, Calvert N, Kuntze S, Smithson H, et al. Clinical guidelines and evidence review for medicines Adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009. Nunes V, Neilson J, O’Flynn N, Calvert N, Kuntze S, Smithson H, et al. Clinical guidelines and evidence review for medicines Adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009.
12.
go back to reference Boustani MA, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20.CrossRef Boustani MA, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20.CrossRef
13.
go back to reference Elliott RA, Marriott JL. Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.CrossRefPubMed Elliott RA, Marriott JL. Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.CrossRefPubMed
14.
go back to reference Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR. Validation of a general measure or treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes. 2004;2:12.CrossRefPubMed Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR. Validation of a general measure or treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes. 2004;2:12.CrossRefPubMed
15.
go back to reference Boyatzis RE. Transforming Qualitative Information: Thematic Analysis and Code Development. CA: Sage Publications; 1998. Boyatzis RE. Transforming Qualitative Information: Thematic Analysis and Code Development. CA: Sage Publications; 1998.
16.
go back to reference Krska J, Morecroft CW, Poole H, Rowe PH. Developing a tool to measure medicines-related quality of life. Int J Pharm Pract. 2012;20(Suppl 1):12. Krska J, Morecroft CW, Poole H, Rowe PH. Developing a tool to measure medicines-related quality of life. Int J Pharm Pract. 2012;20(Suppl 1):12.
17.
go back to reference Royal Pharmaceutical Society and British Medical Association. British National Formulary 63, Pharmaceutical Press: London; 2012. Royal Pharmaceutical Society and British Medical Association. British National Formulary 63, Pharmaceutical Press: London; 2012.
18.
go back to reference Williams S, Weinman J, Dale J. Doctor-patient communication and patient satisfaction: a review. Fam Pract. 1998;15:480–92.CrossRefPubMed Williams S, Weinman J, Dale J. Doctor-patient communication and patient satisfaction: a review. Fam Pract. 1998;15:480–92.CrossRefPubMed
19.
20.
go back to reference Mead N, Bower P. Patient-centred consultations and outcomes in primary care: a review of the literature. Patient Educ Counsel. 2002;48(1):51–61.CrossRef Mead N, Bower P. Patient-centred consultations and outcomes in primary care: a review of the literature. Patient Educ Counsel. 2002;48(1):51–61.CrossRef
21.
22.
go back to reference Saultz JW, Albedaiwi W. Interpersonal continuity of care and patient satisfaction: a critical review. Ann Fam Med. 2004;2:445–51.CrossRefPubMed Saultz JW, Albedaiwi W. Interpersonal continuity of care and patient satisfaction: a critical review. Ann Fam Med. 2004;2:445–51.CrossRefPubMed
23.
go back to reference Adler R, Vasiliadis A, Bickell N. The relationship between continuity and patient satisfaction: a systematic review. Fam Pract. 2010;27(2):171–8.CrossRefPubMed Adler R, Vasiliadis A, Bickell N. The relationship between continuity and patient satisfaction: a systematic review. Fam Pract. 2010;27(2):171–8.CrossRefPubMed
24.
go back to reference Salisbury C, Johnson L, Purgy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care. A retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.CrossRefPubMed Salisbury C, Johnson L, Purgy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care. A retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.CrossRefPubMed
25.
go back to reference Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–41.CrossRefPubMed Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–41.CrossRefPubMed
26.
go back to reference Krska J, Morecroft CW. Views of the general public on the role of pharmacy in public health. J Pharm Health Serv Res. 2010;1(1):33–8. Krska J, Morecroft CW. Views of the general public on the role of pharmacy in public health. J Pharm Health Serv Res. 2010;1(1):33–8.
27.
go back to reference Saramunee K, Krska J, Mackridge AJ, Richards J, Suttajit S, Philips-Howard P. How to enhance the uptake of public health services in community pharmacy? A qualitative study. Res Soc Admin Pharm 2012. Published on-line doi: 10.1016/j.sapharm.2012.05.006. Saramunee K, Krska J, Mackridge AJ, Richards J, Suttajit S, Philips-Howard P. How to enhance the uptake of public health services in community pharmacy? A qualitative study. Res Soc Admin Pharm 2012. Published on-line doi: 10.​1016/​j.​sapharm.​2012.​05.​006.
28.
go back to reference Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public’s health: a systematic review of the peer reviewed and non-peer reviewed literature 1990–2002. Health Expect. 2004;7:191–202.CrossRefPubMed Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public’s health: a systematic review of the peer reviewed and non-peer reviewed literature 1990–2002. Health Expect. 2004;7:191–202.CrossRefPubMed
29.
go back to reference Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of community pharmacist and consumer views. BMC Public Health. 2011;11(582):1–45. Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of community pharmacist and consumer views. BMC Public Health. 2011;11(582):1–45.
30.
go back to reference Eton DT, Oliveira DR, Egginton JS, Ridgeway JL, Odell L, May CR, Montori VM. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas. 2012;3:39–49.CrossRefPubMed Eton DT, Oliveira DR, Egginton JS, Ridgeway JL, Odell L, May CR, Montori VM. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas. 2012;3:39–49.CrossRefPubMed
31.
go back to reference Kairuz T, Bye L, Birdsall R, et al. Identifying compliance issues with prescription medicines among older people: a pilot study. Drugs Aging. 2008;25(2):153–62.CrossRefPubMed Kairuz T, Bye L, Birdsall R, et al. Identifying compliance issues with prescription medicines among older people: a pilot study. Drugs Aging. 2008;25(2):153–62.CrossRefPubMed
36.
go back to reference Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions. Drug Saf. 2012 Published early on-line May 2013 DOI 10.1007/s40264-013-0065-3. Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions. Drug Saf. 2012 Published early on-line May 2013 DOI 10.​1007/​s40264-013-0065-3.
37.
go back to reference Berry DC, Michas IC, Gillie T, Forster M. What do patients want to know about their medicines and what do doctors want to tell them? A comparative study. Psychol Health. 1997;12:467–80.CrossRef Berry DC, Michas IC, Gillie T, Forster M. What do patients want to know about their medicines and what do doctors want to tell them? A comparative study. Psychol Health. 1997;12:467–80.CrossRef
38.
go back to reference Stevenson F. The strategies used by general practitioners when providing information about medicines. Patient Educ Couns. 2001;43(1):97–104.CrossRefPubMed Stevenson F. The strategies used by general practitioners when providing information about medicines. Patient Educ Couns. 2001;43(1):97–104.CrossRefPubMed
39.
go back to reference Elliott RA, Ross DD, Adams AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22(6):805–10.CrossRefPubMed Elliott RA, Ross DD, Adams AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22(6):805–10.CrossRefPubMed
40.
go back to reference Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: a qualitative study. BMJ. 2000;320:484–8.CrossRefPubMed Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: a qualitative study. BMJ. 2000;320:484–8.CrossRefPubMed
41.
go back to reference Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24.CrossRef Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24.CrossRef
42.
go back to reference Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects. Drug Saf. 2007;30:669–75.CrossRefPubMed Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects. Drug Saf. 2007;30:669–75.CrossRefPubMed
43.
go back to reference Anderson CA, Krska J, Murphy E, Avery AJ. On behalf of the yellow card study collaboration. The importance of direct patient reporting of ADRs: a patient perspective. Br J Clin Pharmacol. 2011;72(5):806–22.CrossRefPubMed Anderson CA, Krska J, Murphy E, Avery AJ. On behalf of the yellow card study collaboration. The importance of direct patient reporting of ADRs: a patient perspective. Br J Clin Pharmacol. 2011;72(5):806–22.CrossRefPubMed
44.
go back to reference Krska J, Anderson CA, Murphy E, Avery AJ. On behalf of the yellow card study collaboration. how patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK yellow card scheme. Drug Saf. 2011;34(5):429–36.CrossRefPubMed Krska J, Anderson CA, Murphy E, Avery AJ. On behalf of the yellow card study collaboration. how patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK yellow card scheme. Drug Saf. 2011;34(5):429–36.CrossRefPubMed
45.
go back to reference Weingart SN, Gandhi TK, Seger AC, Seger DL, Borus J, Burdick E, Leape LL, Bates DW. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165:234–40.CrossRefPubMed Weingart SN, Gandhi TK, Seger AC, Seger DL, Borus J, Burdick E, Leape LL, Bates DW. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165:234–40.CrossRefPubMed
46.
go back to reference Krska J, Jones L, McKinney J, Wilson C. Medicines safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098–103.CrossRefPubMed Krska J, Jones L, McKinney J, Wilson C. Medicines safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098–103.CrossRefPubMed
47.
go back to reference Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315:1096–9.CrossRefPubMed Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315:1096–9.CrossRefPubMed
48.
go back to reference Duerden MG, Hughes DA. Generic and therapeutic substitutions in the UK: are they a good thing? Br J Clin Pharmacol. 2010;70:335–41.CrossRefPubMed Duerden MG, Hughes DA. Generic and therapeutic substitutions in the UK: are they a good thing? Br J Clin Pharmacol. 2010;70:335–41.CrossRefPubMed
49.
go back to reference Krska J, Allison K, Delargy M, Murray L, Smith H. Implementing a statin switching programme in primary care: patients’ views and experiences. Br J Clin Pharmacol. 2012;74:147–53.CrossRefPubMed Krska J, Allison K, Delargy M, Murray L, Smith H. Implementing a statin switching programme in primary care: patients’ views and experiences. Br J Clin Pharmacol. 2012;74:147–53.CrossRefPubMed
50.
go back to reference Thompson A, Green S, Dubois S, et al. Evaluation of patient satisfaction with switching medication. Prescriber. 2006;17:27–35.CrossRef Thompson A, Green S, Dubois S, et al. Evaluation of patient satisfaction with switching medication. Prescriber. 2006;17:27–35.CrossRef
51.
go back to reference Hassali MA, Shafie AA, Jamshed A, Ibrahim M, Awaisu A. Consumers’ views on generic medicine: a review of literature. Int J Pharm Pract. 2009;17:79–88.PubMed Hassali MA, Shafie AA, Jamshed A, Ibrahim M, Awaisu A. Consumers’ views on generic medicine: a review of literature. Int J Pharm Pract. 2009;17:79–88.PubMed
52.
go back to reference Richards C, Coulter A. Is the NHS becoming more patient centred? Trends from the national surveys of NHS patients in England, 2002–2007. 2007. Picker Institute. Richards C, Coulter A. Is the NHS becoming more patient centred? Trends from the national surveys of NHS patients in England, 2002–2007. 2007. Picker Institute.
53.
go back to reference Cox K, Britten N, Hooper R, White P. Patients’ involvement in decisions about medicines: GPs’ perceptions of their preferences. Br J Gen Pract. 2007;57:777–84.PubMed Cox K, Britten N, Hooper R, White P. Patients’ involvement in decisions about medicines: GPs’ perceptions of their preferences. Br J Gen Pract. 2007;57:777–84.PubMed
Metadata
Title
Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study
Authors
Janet Krska
Charles W. Morecroft
Helen Poole
Philip H. Rowe
Publication date
01-12-2013
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2013
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9841-5

Other articles of this Issue 6/2013

International Journal of Clinical Pharmacy 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.